Search results
If a fingernail or toenail has a new or changing dark streak, it’s time to see a dermatologist for a skin cancer check. That dark streak could be melanoma, the most serious type of skin cancer. Not every dark streak is a melanoma, but it’s always good to have a dermatologist examine one.
9 lip 2018 · If a fingernail or toenail has a new or changing dark streak, it’s time to see a dermatologist for a skin cancer check. That dark streak could be melanoma, the most serious type of skin cancer. Not every dark streak is a melanoma, but it’s always good to have a dermatologist examine one.
3 mar 2022 · Dermoscopy, diagnostic imaging and histopathologic and mycological analyses may be necessary for diagnosis. Nail findings concerning for malignancy should be promptly referred to a dermatologist for evaluation and biopsy. Nail disease management requires a targeted treatment approach.
12 maj 2021 · Here, we discuss the various therapies, including topicals, injectables, systemic, lasers, and complementary therapies, that have been explored for the treatment of nail psoriasis. We describe in detail the recent clinical trials that have evaluated their use and provide management recommendations.
1 lis 2014 · Amorolfine 5% nail lacquer in association with two pulses of itraconazole therapy was at least as effective as three pulses of itraconazole alone in moderate‐to‐severe fingernail onychomycosis caused by Candida. 127 The combination was also shown to be more effective in severe toenail onychomycosis. 128 A multicentre randomized controlled ...
12 cze 2023 · The clinical findings range from the complete loss of nails (anonychia), eg in some cases of congenital ectodermal dysplasia, to thickened and discoloured nails seen in pachyonychia congenita. Congenital nail disorders are very rare and are not considered further on this website.
This review shows that patients with CTS may first consult a dermatologist because of nail changes even in the absence of classic neurologic complaints of numbness and tingling.
